Skip to main content
SpringerLink
Log in

Complexation of VEGF with Bevacizumab Decreases VEGF Clearance in Rats

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. J. Rak, B. St. Croix, and R. Kerbel. Consequences of angiogenesis for tumor progression, metastasis, and cancer therapy.Anticancer Drugs 6:3-18 (1995).

    Google Scholar 

  2. J. Folkman. What is the evidence that tumors are angiogenesis dependent? J.Natl.Cancer Inst. 82:4-6 (1990).

    PubMed  Google Scholar 

  3. N. Ferrara and T. David-Smith. The biology of vascular endothelial growth factor. Endocr.Rev. 18:4-22 (1997).

    PubMed  Google Scholar 

  4. S. Eppler, E. R. McCluskey, T. D. Henry, M. Simons, F. J. Giordano, and T. F. Zioncheck. Unique kinetics and hemodynamics of vascular endothelial growth factor (rhVEGF) following intracoronary and intravenous infusion in humans. J.Am.Col.Cardiol. 35:73A-74A (2000).

    Google Scholar 

  5. H. P. Gerber, J. Kowalski, D. Sherman, D. A. Eberhard, and N. Ferrara. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. Cancer Res. 60:6253-6258 (2000).

    PubMed  Google Scholar 

  6. L. G. Presta, H. Chen, S. J. O'Connor, V. Chisolm, Y. G. Meng, L. Krummen, M. Winkler, and N. Ferrara. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 57:4593-4599 (1997).

    PubMed  Google Scholar 

  7. N. E. Simister, I. E. Jacobowitz, J. C. Ahouse, and C. M. Story. New functions of the MHC class I-related Fc receptor, FcRn. Biochem.Soc.Trans. 25:481-486 (1997).

    PubMed  Google Scholar 

  8. Y. S. Lin, C. Nguyen, J. L. Medoza, E. Escandon, D. Fei, Y. G. Meng, and N. B. Modi. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J.Pharmacol.Exp.Ther. 288:371-378 (1999).

    PubMed  Google Scholar 

  9. K. J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara. Inhibition of vascular endothelial growth factorinduced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844 (1993).

    PubMed  Google Scholar 

  10. E. Bergsland, H. Hurwitz, L. Fehrenbacher, N. J. Meropol, W. F. Novotny, J. Gaudreault, G. Lieberman, and F. Kabbinavar. A randomized phase II trial comparing rhuMAb VEGF (recombinant humanized monoclonal antibody to vascular endothelial growth factor) plus 5-fluorouracil/leucovorin (FU/LV) to FU/LV alone in patients with metastatic colorectal cancer. PASCO 19:242a (2000).

    Google Scholar 

  11. R. F. DeVore, L. Fehrenbacher, R. S. Herbet, C. J. Langer, K. Kelly, J. Gaudreault, E. Holmgren, W. F. Novotny, and F. Kabbinavar. A randomized phase II trial comparing rhuMAb VEGF (recombinant humanized monoclonal antibody to vascular endothelial growth factor) plus carboplatin/paclitaxel (CP) to CP alone in patients with stage IIIB/IV NSCLC. PASCO 19:485a (2000).

    Google Scholar 

  12. M. S. Gordon, K. Margolin, M. Talpaz, G. W. Sledge Jr., E. Holmgren, R. Benjamin, S. Stalter, S. Shak, and D. C. Adelman. Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J.Clin.Oncol. 19:843-850 (2001).

    PubMed  Google Scholar 

  13. B. Q. Shen, D. Y. Lee, H. P. Gerber, B. A. Keyt, N. Ferrara, and T. F. Zioncheck. Homologous up-regulation of KDR/Flk-1 receptor expression by vacular endothelial growth factor in vitro. J.Biol.Chem. 273:29979-29985 (1998).

    PubMed  Google Scholar 

  14. J. Liu, P. Lester, S. Builder, and S. J. Shire. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE. Biochemistry 34:10474-10482 (1995).

    PubMed  Google Scholar 

  15. J. A. Fox, T. E. Hotaling, C. Struble, J. Ruppel, D. J. Bates, and M. B. Schoenhoff. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in Cynomolgus monkeys. J.Pharmacol.Exp.Ther. 279:1000-1008 (1996).

    PubMed  Google Scholar 

  16. M. Schoenhoff, D. Bate, J. Ruppel, D. Fei, J. A. Fox, D. Thomas, and P. Jardieu. Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in cynomolgus monkeys. J.Allergy Clin.Immunol. 95:356 (1995).

    Google Scholar 

  17. H. Milgrom, R. B. Fick, J. Q. Su, J. D. Reimann, R. K. Bush, M. L. Watrous, and W. J. Metzger. Treatment of allergic asthma with monoclonal anti-IgE antibody. N.Engl.J.Med. 341:1966-1973 (1999).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical and Experimental Pharmacology, Genentech, Inc., South San Francisco, California, 94080

    Vanessa Hsei & Jacques Gaudreault

  2. Department of Physiology, Genentech, Inc., South San Francisco, California

    Geralyn G. DeGuzman

  3. Vacaville Quality Control, Genentech, Inc., Vacaville, California

    Allison Nixon

Authors
  1. Vanessa Hsei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geralyn G. DeGuzman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allison Nixon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacques Gaudreault
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vanessa Hsei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsei, V., DeGuzman, G.G., Nixon, A. et al. Complexation of VEGF with Bevacizumab Decreases VEGF Clearance in Rats. Pharm Res 19, 1753–1756 (2002). https://doi.org/10.1023/A:1020778001267

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020778001267

Search

Navigation